BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8135145)

  • 1. Effects of granulocyte-macrophage colony stimulating factor on soluble interleukin-2 receptor serum levels and their relation to neopterin and tumor necrosis factor-alpha in cancer patients.
    Crispino S; Lissoni P; Ardizzoia A; Rovelli F; Perego MS; Grassi MG; Barni S; Pittalis S; Tancini G
    J Biol Regul Homeost Agents; 1993; 7(3):92-4. PubMed ID: 8135145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of interactions among markers of macrophage functions in metastatic solid tumors: neopterin levels in relation to those of tumor necrosis factor-alpha and of soluble interleukin-2 receptors.
    Lissoni P; Brivio F; Fumagalli L; Galimberti C; Cataldo M; Marsili MT; Brivio O; Barni S; Tancini G; Angelini A
    J Biol Regul Homeost Agents; 1994; 8(1):32-5. PubMed ID: 7976492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer.
    Gadducci A; Ferdeghini M; Malagnino G; Prontera C; Fanucchi A; Annicchiarico C; Bianchi R; Fioretti P; Facchini V
    Gynecol Oncol; 1994 Mar; 52(3):386-91. PubMed ID: 8157196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis.
    Nassonov EL; Samsonov MY; Tilz GP; Beketova TV; Semenkova EN; Baranov A; Wachter H; Fuchs D
    J Rheumatol; 1997 Apr; 24(4):666-70. PubMed ID: 9101499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Eosinophil colony stimulating factor (Eo-CSF) activity and soluble interleukin-2 receptor (sIL-2R) in patients with reactive eosinophilia].
    Watanabe K; Enokihara H; Saito K; Furusawa S
    Arerugi; 1995 Nov; 44(11):1317-21. PubMed ID: 8857112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cellular immunity in pregnancy-induced hypertensive diseases].
    Schröcksnadel H; Herold M; Steckel-Berger G; Fuchs D; Wachter H; Dapunt O
    Geburtshilfe Frauenheilkd; 1992 Oct; 52(10):592-5. PubMed ID: 1294433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations of circulating endogenous granulocyte-macrophage colony-stimulating factor in HIV-1-seropositive injecting drug users.
    Herold M; Meise U; Günther V; Rössler H; Zangerle R
    Presse Med; 1994 Dec; 23(40):1854-8. PubMed ID: 7899316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host disease.
    Miyamoto T; Akashi K; Hayashi S; Gondo H; Murakawa M; Tanimoto K; Harada M; Niho Y
    Bone Marrow Transplant; 1996 Feb; 17(2):185-90. PubMed ID: 8640164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between macrophage and T helper-2 lymphocyte functions in human neoplasms: neopterin, interleukin-10 and interleukin-6 blood levels in early or advanced solid tumors.
    Lissoni P; Rovelli F; Tisi E; Brivio F; Ardizzoia A; Barni S; Tancini G; Saudelli M; Cesana E; Viganò MG
    J Biol Regul Homeost Agents; 1995; 9(4):146-9. PubMed ID: 8844339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor administration is associated with increased endogenous production of M-CSF and G-CSF but not GM-CSF in human cancer patients.
    Logan TF; Gooding W; Kirkwood JM; Shadduck RK
    Exp Hematol; 1996 Jan; 24(1):49-53. PubMed ID: 8536792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Soluble interleukin-2 receptor and macrophage colony-stimulating factor (M-CSF) in cerebrospinal fluid in patients with hematological malignancies: clinical significance in adult T-cell leukemia with meningeal infiltration].
    Tanaka K; Shiraishi K; Sakamoto A; Fukahori S; Jojima H; Osabe S; Mizunoe K; Masuchi K; Imamura Y; Honda J; Egami K; Natori H; Oizumi K
    Rinsho Ketsueki; 1996 Jul; 37(7):610-7. PubMed ID: 8779781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
    Bodey B; Psenko V; Lipsey AL; Kaiser HE
    Anticancer Res; 1996; 16(1):219-24. PubMed ID: 8615612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2.
    Lissoni P; Tisi E; Brivio F; Barni S; Rovelli F; Perego M; Tancini G
    Eur J Cancer; 1991; 27(8):1014-6. PubMed ID: 1832885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma elastase-alpha 1-antitrypsin, neopterin, tumor necrosis factor, and soluble interleukin-2 receptor after prolonged exercise.
    Dufaux B; Order U
    Int J Sports Med; 1989 Dec; 10(6):434-8. PubMed ID: 2628363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between pretreatment serum levels of neopterin and response to interleukin-2 immunotherapy in cancer patients.
    Lissoni P; Barni S; Ardizzoia A; Scardino E; Tancini G; Viganò MG
    J Biol Regul Homeost Agents; 1995; 9(1):21-3. PubMed ID: 8553904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha.
    Grüngreiff K; Reinhold D; Ansorge S
    Cytokine; 1999 Dec; 11(12):1076-80. PubMed ID: 10623433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy.
    Hahn G; Stuhlmüller B; Hain N; Kalden JR; Pfizenmaier K; Burmester GR
    J Clin Invest; 1993 Mar; 91(3):862-70. PubMed ID: 8450066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional expression of interleukin 2 receptor in a human factor-dependent megakaryoblastic leukemia cell line: evidence that granulocyte-macrophage colony-stimulating factor inhibits interleukin 2 binding to its receptor.
    Kanakura Y; Sugahara H; Mitsui H; Ikeda H; Furitsu T; Yagura H; Kitayama H; Kanayama Y; Matsuzawa Y
    Cancer Res; 1993 Feb; 53(3):675-80. PubMed ID: 8425202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum levels of neopterin and soluble interleukin-2 receptor in intrahepatic cholestasis of pregnancy.
    Wang Z; Dong M; Chu H; He J
    Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1067-70. PubMed ID: 15488124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.